Virpax Pharmaceuticals (VRPX) News Today → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free VRPX Stock Alerts $0.78 -0.02 (-2.50%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 12:14 AM | uk.investing.comVirpax Pharmaceuticals sets terms for $2.25 million offeringMay 16 at 3:27 AM | wsj.comVirpax Pharmaceuticals Inc.May 15, 2024 | marketwatch.comVirpax Pharmaceuticals Shares Hit All-Time Low After Equity SaleMay 15, 2024 | investorplace.comWhy Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?May 15, 2024 | businesswire.comVirpax Announces Pricing of $2.25 Million Public OfferingMay 14, 2024 | investorplace.comVRPX Stock Earnings: Virpax Pharmaceuticals Reported Results for Q1 2024May 13, 2024 | businesswire.comVirpax Pharmaceuticals Reports 2024 First Quarter Results and Recent DevelopmentsMay 12, 2024 | americanbankingnews.comVirpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Sees Large Decline in Short InterestMay 8, 2024 | msn.comVirpax Pharmaceuticals' Probudur Shows Promising Results in Pain Management StudyApril 30, 2024 | businesswire.comVirpax Announces Results of Maximum Tolerated Dose Study for Probudur™April 24, 2024 | investorplace.comVRPX Stock Earnings: Virpax Pharmaceuticals Misses EPS for Q4 2023April 2, 2024 | msn.comVirpax Pharmaceuticals Set for Transformative Year with High Hopes for Non-Addictive Pain Management SolutionsMarch 26, 2024 | businesswire.comVirpax Pharmaceuticals Reports 2023 Year-End ResultsMarch 1, 2024 | marketbeat.comTrading was temporarily halted for "VRPX" at 09:03 AM with a stated reason of "LULD pause."March 1, 2024 | marketbeat.comTrading was temporarily halted for "VRPX" at 07:02 PM with a stated reason of "News pending."February 27, 2024 | finance.yahoo.comVirpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid PriceFebruary 27, 2024 | businesswire.comVirpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid PriceFebruary 27, 2024 | businesswire.comVirpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.February 12, 2024 | msn.comVirpax Pharmaceuticals Reports Promising Results in Probudur Pilot StudyFebruary 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Virpax Pharmaceuticals (VRPX) and I-MAB (IMAB)February 7, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and EyePoint Pharmaceuticals (EYPT)January 23, 2024 | investing.comVirpax Pharmaceuticals Inc (VRPX)December 29, 2023 | msn.comVirpax Pharmaceuticals shareholders okay reverse stock splitDecember 28, 2023 | msn.comTitan Pharmaceuticals to conduct 1-for-20 reverse stock splitNovember 22, 2023 | seekingalpha.comVRPX Virpax Pharmaceuticals, Inc.November 18, 2023 | markets.businessinsider.comPromising Pipeline Developments and Market Opportunities Drive Buy Rating for Virpax PharmaceuticalsNovember 17, 2023 | msn.comVirpax Pharmaceuticals gets non-compliance notice from NasdaqNovember 17, 2023 | msn.comVirpax Pharmaceuticals CEO and Chairman resigns on ongoing litigationNovember 17, 2023 | finance.yahoo.comVirpax Pharmaceuticals Announces Leadership TransitionNovember 17, 2023 | finance.yahoo.comVirpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q FilingNovember 15, 2023 | msn.comVirpax Pharmaceuticals GAAP EPS of -$0.51October 31, 2023 | finance.yahoo.comVirpax Pharmaceuticals Announces that Envelta™ Remains on Track for Trial in Humans Following FDA ReviewSeptember 28, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Virpax Pharmaceuticals (VRPX), Kura Oncology (KURA)September 27, 2023 | finance.yahoo.comVirpax Pharmaceuticals Announces Results of Probudur™ Dose Escalation StudiesSeptember 26, 2023 | finance.yahoo.comVirpax Pharmaceuticals to Present at the LD Micro Main Event XVISeptember 21, 2023 | businesswire.comAltasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like VirusesSeptember 18, 2023 | finance.yahoo.comVirpax Pharmaceuticals Announces the Formation of Novvae™ PharmaceuticalsSeptember 5, 2023 | msn.comVirpax slips as court rules in favor of Scilex and SorrentoAugust 28, 2023 | finance.yahoo.comVirpax® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment ConferenceAugust 15, 2023 | markets.businessinsider.comMaxim Group Remains a Buy on Virpax Pharmaceuticals (VRPX)August 10, 2023 | finance.yahoo.comVirpax Pharmaceuticals Files Provisional Patent Application for NSAID Formulation and MethodJuly 24, 2023 | finance.yahoo.comVirpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023July 13, 2023 | finance.yahoo.comVirpax Pharmaceuticals Files Provisional Patent Application for Intranasal DeliveryJune 21, 2023 | finance.yahoo.comVirpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke CouncilJune 20, 2023 | finance.yahoo.comVirpax Pharmaceuticals Announces CFO TransitionJune 13, 2023 | finance.yahoo.comVirpax Pharmaceuticals to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ETMay 12, 2023 | msn.comVirpax Pharmaceuticals GAAP EPS of -$0.13 beats by $0.17May 10, 2023 | finance.yahoo.comVirpax Pharmaceuticals To Present at Upcoming CB Tech Watch SeminarMay 4, 2023 | finance.yahoo.comVirpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023April 27, 2023 | finance.yahoo.comVirpax Pharmaceuticals Engages Dr. Pardeep Gupta to Assist in Development of Company’s Lead Asset, Probudur™ Get Virpax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRPX and its competitors with MarketBeat's FREE daily newsletter. Email Address [URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over? Click here for our #1 AI Stock for 2024 and Beyond VRPX Media Mentions By Week VRPX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRPX News Sentiment▼0.080.42▲Average Medical News Sentiment VRPX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRPX Articles This Week▼80▲VRPX Articles Average Week Get Virpax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRPX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CYTO News ATXI News ONCO News NTBL News SNOA News SXTP News CWBR News CNSP News SLRX News CYCC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRPX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
